300 related articles for article (PubMed ID: 32501510)
1. Japanese encephalitis virus-primed CD8+ T cells prevent antibody-dependent enhancement of Zika virus pathogenesis.
Chen D; Duan Z; Zhou W; Zou W; Jin S; Li D; Chen X; Zhou Y; Yang L; Zhang Y; Shresta S; Wen J
J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32501510
[TBL] [Abstract][Full Text] [Related]
2. Japanese encephalitis virus E protein domain III immunization mediates cross-protection against Zika virus in mice via antibodies and CD8
Duan ZL; Zou WW; Chen D; Zhu JY; Wen JS
Virus Res; 2024 Jul; 345():199376. PubMed ID: 38643856
[TBL] [Abstract][Full Text] [Related]
3. The effects of Japanese encephalitis virus antibodies on Zika virus infection.
He X; Lang X; Yu J; Zhu L; Qin Z; Liu X; Chen P; Dai C; Chen T; Li X; Chen Y; Zhou D; Fang W; Xiao W; Zhang B; Xie Q; Wu Q; Zhao W
Med Microbiol Immunol; 2020 Apr; 209(2):177-188. PubMed ID: 32078028
[TBL] [Abstract][Full Text] [Related]
4. Japanese Encephalitis Virus Vaccination Elicits Cross-Reactive HLA-Class I-Restricted CD8 T Cell Response Against Zika Virus Infection.
Tarbe M; Dong W; Hu G; Xu Y; Sun J; Grayo S; Chen X; Qin C; Zhao J; Liu L; Li X; Leng Q
Front Immunol; 2020; 11():577546. PubMed ID: 33101303
[TBL] [Abstract][Full Text] [Related]
5. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
[TBL] [Abstract][Full Text] [Related]
6. T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine.
Wang R; Zhen Z; Turtle L; Hou B; Li Y; Wu N; Gao N; Fan D; Chen H; An J
Appl Microbiol Biotechnol; 2020 Aug; 104(15):6779-6789. PubMed ID: 32556415
[TBL] [Abstract][Full Text] [Related]
7. Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine.
Lima NS; Moon D; Darko S; De La Barrera RA; Lin L; Koren MA; Jarman RG; Eckels KH; Thomas SJ; Michael NL; Modjarrad K; Douek DC; Trautmann L
Front Immunol; 2021; 12():640190. PubMed ID: 33717194
[TBL] [Abstract][Full Text] [Related]
8. Analysis of cross-reactivity between flaviviruses with sera of patients with Japanese encephalitis showed the importance of neutralization tests for the diagnosis of Japanese encephalitis.
Maeki T; Tajima S; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Lim CK; Saijo M
J Infect Chemother; 2019 Oct; 25(10):786-790. PubMed ID: 31105002
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
Front Immunol; 2018; 9():597. PubMed ID: 29740424
[TBL] [Abstract][Full Text] [Related]
10. Serological evidence of DENV, JEV, and ZIKV among the indigenous people (Orang Asli) of Peninsular Malaysia.
Khor CS; Mohd-Rahim NF; Hassan H; Tan KK; Zainal N; Teoh BT; Sam SS; Khoo JJ; Lee HY; Lim YA; Abubakar S
J Med Virol; 2020 Aug; 92(8):956-962. PubMed ID: 31814135
[TBL] [Abstract][Full Text] [Related]
11. Differential Longevity of Memory CD4 and CD8 T Cells in a Cohort of the Mothers With a History of ZIKV Infection and Their Children.
Badolato-Corrêa J; Carvalho FR; Paiva IA; Familiar-Macedo D; Dias HG; Pauvolid-Corrêa A; Fernandes-Santos C; Lima MDRQ; Gandini M; Silva AA; Baeta Cavalcanti SM; de Oliveira SA; de Oliveira Vianna RA; de Azeredo EL; Cardoso CAA; Grifoni A; Sette A; Weiskopf D; de-Oliveira-Pinto LM
Front Immunol; 2021; 12():610456. PubMed ID: 33679748
[No Abstract] [Full Text] [Related]
12. Survey on neutralizing antibodies against Zika virus eighteen months post-outbreak in two southern Thailand communities.
Densathaporn T; Sangthong R; Sakolnapa M; Surasombatpattana S; Kemapunmanus M; Masrinoul P; Yoksan S; McNeil EB; Chongsuvivatwong V
BMC Infect Dis; 2020 Dec; 20(1):921. PubMed ID: 33272192
[TBL] [Abstract][Full Text] [Related]
13. Dengue virus-reactive CD8
Wen J; Elong Ngono A; Regla-Nava JA; Kim K; Gorman MJ; Diamond MS; Shresta S
Nat Commun; 2017 Nov; 8(1):1459. PubMed ID: 29129917
[TBL] [Abstract][Full Text] [Related]
14. Dengue Virus and Zika Virus Serological Cross-reactivity and Their Impact on Pathogenesis in Mice.
Watanabe S; Tan NWW; Chan KWK; Vasudevan SG
J Infect Dis; 2019 Jan; 219(2):223-233. PubMed ID: 30085051
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the Safety of West Nile Virus Immunity During Congenital Zika Virus Infection in Mice.
Acklin JA; Cattle JD; Moss AS; Brown JA; Foster GA; Krysztof D; Stramer SL; Lim JK
Front Immunol; 2021; 12():686411. PubMed ID: 34220838
[TBL] [Abstract][Full Text] [Related]
16. Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors.
Li M; Zhao L; Zhang C; Wang X; Hong W; Sun J; Liu R; Yu L; Wang J; Zhang F; Jin X
PLoS One; 2018; 13(7):e0200478. PubMed ID: 30044839
[TBL] [Abstract][Full Text] [Related]
17. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
[TBL] [Abstract][Full Text] [Related]
18. Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine.
Li Y; Merbah M; Wollen-Roberts S; Beckman B; Mdluli T; Curtis DJ; Currier JR; Mendez-Rivera L; Dussupt V; Krebs SJ; De La Barrera R; Michael NL; Paquin-Proulx D; Eller MA; Koren MA; Modjarrad K; Rolland M
EBioMedicine; 2023 Nov; 97():104815. PubMed ID: 37793212
[TBL] [Abstract][Full Text] [Related]
19. Epitope(s) involving amino acids of the fusion loop of Japanese encephalitis virus envelope protein is(are) important to elicit protective immunity.
Fan Y-C; Chen J-M; Chen Y-Y; Ke Y-D; Chang G-JJ; Chiou S-S
J Virol; 2024 Apr; 98(4):e0177323. PubMed ID: 38530012
[TBL] [Abstract][Full Text] [Related]
20. The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis.
Langerak T; Mumtaz N; Tolk VI; van Gorp ECM; Martina BE; Rockx B; Koopmans MPG
PLoS Pathog; 2019 Apr; 15(4):e1007640. PubMed ID: 30998804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
